Enanta Pharmaceuticals Inc. buy BiotechBee
Start price
11.01.23
/
50%
€46.60
Target price
31.12.25
€60.00
Performance (%)
-30.47%
End price
05.05.23
€32.40
Summary
This prediction ended on 05.05.23 with a price of €32.40. The BUY prediction by BiotechBee for Enanta Pharmaceuticals Inc. performed very badly with a performance of -30.47%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Enanta Pharmaceuticals Inc. | 0.000% | 0.000% | 115.789% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
According to BiotechBee what are the pros and cons of Enanta Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 60,0
In the thread Trading Enanta Pharmaceuticals Inc.
Buy beendet
Stopped prediction by BiotechBee for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.65
28.09.25
28.09.25
€10.00
30.09.27
30.09.27
20.92%
18.10.25
18.10.25
Could be very worthwhile Investment >20% year
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.30
16.09.24
16.09.24
€18.00
28.02.27
28.02.27
-41.26%
14.12.24
14.12.24
Could be very worthwhile Investment >20% year

